Leuven, Vlaams-Brabant, Belgium The venture was found in Europe in Belgium. The main department of described VC is located in the Leuven.
Comparing to the other companies, this Agri Investment Fund performs on 4 percentage points less the average number of lead investments. The increased amount of exits for fund were in 2014. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2008. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Agri Investment Fund, startups are often financed by VIB, Qbic, PMV. The meaningful sponsors for the fund in investment in the same round are VIB, Qbic Fund, PMV. In the next rounds fund is usually obtained by The Institute for the Promotion of Innovation by Science and Technology in Flanders.
The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Biotechnology, Food and Beverage. Among the various public portfolio startups of the fund, we may underline AgroSavfe, Aphea.Bio, Okapi Sciences For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
Related Funds
| Fund Name | Location |
| Alcumus Group | Cardiff, United Kingdom, Wales |
| Blue Titan Ventures | Brooklyn, New York, United States |
| Boston Life Science Venture | Taipei, Taiwan |
| Dunamu & Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
| FA Technology Ventures | Massachusetts, United States, Waltham |
| Faith | Japan, Kyoto, Kyoto Prefecture |
| Hongfu Ruiying | China, Guangdong, Shenzhen |
| Kingdom Holding Company | Ar Riyad, Riyadh, Saudi Arabia |
| NJTC Venture Fund | Mount Laurel, New Jersey, United States |
| ORSO Japan | Japan, Tokyo |
| Otter Capital | California, Palo Alto, United States |
| Polsky Center for Entrepreneurship and Innovation | Chicago, Illinois, United States |
| Resources Connection | California, Costa Mesa, United States |
| Rhino Ventures (Formerly Vancouver Founder Fund) | British Columbia, Canada, Vancouver |
| Schooner Capital | Boston, Massachusetts, United States |
| SEMA Translink Investment | Seoul, Seoul-t'ukpyolsi, South Korea |
| Shanghai Lingyue Yunshang Chuangye Touzi | China, Qingpu, Shanghai |
| Taylor Frigon | California, San Luis Obispo, United States |
| TIM | Italy, Lazio, Roma |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Aphea.Bio | $82M | 11 Jul 2023 | Ghent, East Flanders, Belgium | ||
Aphea.Bio | $21M | 14 Apr 2021 | Ghent, East Flanders, Belgium | ||
Aphea.Bio | $4M | 01 Apr 2021 | Ghent, East Flanders, Belgium | ||
Animab | $4M | 27 Oct 2020 | Belgium, East Flanders | ||
Virovet | $7M | 28 May 2020 | Leuven, Flemish Brabant, Belgium | ||
Biotalys | $41M | 30 Jul 2019 | Ghent, East Flanders, Belgium | ||
Aphea.Bio | $9M | 26 Jun 2017 | Ghent, East Flanders, Belgium | ||
Okapi Sciences | $10M | 03 Nov 2008 | Belgium, Flemish Brabant |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Aphea.Bio | $82M | 11 Jul 2023 | Ghent, East Flanders, Belgium | ||
Aphea.Bio | $21M | 14 Apr 2021 | Ghent, East Flanders, Belgium | ||
Aphea.Bio | $4M | 01 Apr 2021 | Ghent, East Flanders, Belgium | ||
Animab | $4M | 27 Oct 2020 | Belgium, East Flanders | ||
Virovet | $7M | 28 May 2020 | Leuven, Flemish Brabant, Belgium | ||
Biotalys | $41M | 30 Jul 2019 | Ghent, East Flanders, Belgium | ||
Aphea.Bio | $9M | 26 Jun 2017 | Ghent, East Flanders, Belgium | ||
Okapi Sciences | $10M | 03 Nov 2008 | Belgium, Flemish Brabant |
